Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Myszkow

5 clinical trials in Myszkow, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Myszkow at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Myszkow

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Arteriosclerosis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 765845
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Myszkow

What the registry says about research in the country

01 Cardiovascular Prevention

Innovative research focusing on heart failure prevention through combination therapy studies. The trials explore new treatment approaches using combined medications to reduce cardiovascular mortality risks.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Combination Therapy Assessment

These studies aim to advance preventive cardiology strategies for high-risk patients.

02 Post-Myocardial Infarction Care

Clinical research examining novel therapeutic approaches for patients who have experienced an acute myocardial infarction. The trials evaluate new compounds for improving outcomes after heart attacks.

  • Post-Heart Attack Treatment
  • Drug Safety Assessment
  • Dose Optimization Studies

Research focuses on developing optimal treatment strategies for heart attack survivors.

03 Atherosclerosis Prevention

Advanced studies investigating treatments for primary prevention of atherosclerotic cardiovascular disease. The research examines innovative approaches to prevent major adverse cardiovascular events.

  • Cardiovascular Event Prevention
  • Atherosclerosis Management
  • Long-term Cardiovascular Outcomes

These trials aim to reduce the risk of serious cardiovascular complications in high-risk populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.